phosphatidylcholines has been researched along with Hepatitis C, Chronic in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Abomughaid, M; Coorssen, JR; Douglas, MW; George, J; Gloss, BS; Malladi, C; Pickford, R; Read, SA; Tay, ESE | 1 |
Ampleeva, NP; Pavelkina, VF | 1 |
Glushenkov, DV; Maevskaia, MV; Tel'nykh, IuV | 1 |
Rockey, DC | 1 |
Bares, JM; Berger, J; Kowdley, KV; Messner, DJ; Nelson, JE; Schildt, S; Standish, LJ | 1 |
1 review(s) available for phosphatidylcholines and Hepatitis C, Chronic
Article | Year |
---|---|
New therapies in hepatitis C virus and chronic liver disease: antifibrotics.
Topics: Colchicine; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-gamma; Interleukin-10; Liver Cirrhosis; Phosphatidylcholines; Silymarin; Ursodeoxycholic Acid | 2006 |
3 trial(s) available for phosphatidylcholines and Hepatitis C, Chronic
Article | Year |
---|---|
[Comparative effectiveness hepatotropic activity remaxol and Essentiale N in chronic viral hepatitis].
Topics: Adult; Antioxidants; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Function Tests; Middle Aged; Phosphatidylcholines; Succinates; Treatment Outcome; Young Adult | 2014 |
[The use of hepatoprotector LiverPro in combined therapy of chronic viral hepatitis C].
Topics: Adult; Antiviral Agents; Drug Combinations; Drug Therapy; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver; Male; Phosphatidylcholines; Silybin; Silymarin; Young Adult | 2008 |
Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Ferritins; Hepatitis C, Chronic; Humans; Iron-Binding Proteins; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Phosphatidylcholines; Silybum marianum; Silymarin; Transferrin | 2008 |
1 other study(ies) available for phosphatidylcholines and Hepatitis C, Chronic
Article | Year |
---|---|
PEMT Mediates Hepatitis C Virus-Induced Steatosis, Explains Genotype-Specific Phenotypes and Supports Virus Replication.
Topics: Cholesterol; Fatty Liver; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Phenotype; Phosphatidylcholines; Phosphatidylethanolamine N-Methyltransferase; Transferases; Virus Replication | 2023 |